![](/img/cover-not-exists.png)
E32Clinical use of immune-checkpoint inhibitors: focus on late immune-related adverse events and pseudoprogression
Sini, C, Carta, A M, Bardino, G, Saba, E M, Coinu, A, Defraia, E, Ortu, S, Schintu, M G, Pira, T, Frau, B, Soru, G, Masale, AVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx426.031
Date:
October, 2017
File:
PDF, 76 KB
2017